Brevan Howard Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,932	Closed	-$93.8K	–	1748
2025 Q1	$93.8K	Buy	+10,932	New	+$93.8K	﹤0.01%	1010
2024 Q3	–	Sell	-25,801	Closed	-$109K	–	1083
2024 Q2	$109K	Buy	+25,801	New	+$109K	﹤0.01%	913